We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$91.6M
Cap. Flow %
6.65%
Top 10 Hldgs %
28.56%
Holding
1,934
New
622
Increased
464
Reduced
326
Closed
465

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Communication Services 8.62%
3 Healthcare 8.45%
4 Financials 8.14%
5 Consumer Discretionary 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIC icon
1101
Global Industrial
GIC
$1.49B
$46K ﹤0.01%
1,602
-400
-20% -$12.1K
GKOS icon
1102
Glaukos
GKOS
$10.6B
$46K ﹤0.01%
+1,500
New +$45.4K
MAT icon
1103
CALL
Mattel
MAT
$4.23B
$46K ﹤0.01%
3,500
-300
-8% -$4.68K
NVDA icon
1104
PUT
NVIDIA
NVDA
$5.42T
$46K ﹤0.01%
+8,000
New +$47K
UFPT icon
1105
UFP Technologies
UFPT
$2.43B
$46K ﹤0.01%
1,576
-1,168
-43% -$33.8K
PLSE icon
1106
Pulse Biosciences
PLSE
$3.02B
$45K ﹤0.01%
+3,340
New +$63.4K
PMD
1107
DELISTED
Psychemedics Corporation
PMD
$45K ﹤0.01%
2,104
-2,000
-49% -$41.5K
KTWO
1108
DELISTED
K2M Group Holdings, Inc
KTWO
$45K ﹤0.01%
2,350
+401
+21% +$7.94K
PKOH icon
1109
Park-Ohio Holdings
PKOH
$761M
$44K ﹤0.01%
1,133
-167
-13% -$7.14K
RMBS icon
1110
Rambus
RMBS
$11B
$44K ﹤0.01%
+3,280
New +$43.9K
SHOO icon
1111
Steven Madden
SHOO
$3.55B
$44K ﹤0.01%
+1,500
New +$45.3K
TNDM icon
1112
Tandem Diabetes Care
TNDM
$1.56B
$44K ﹤0.01%
8,840
+8,803
+23,792% +$28.4K
ODT
1113
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$44K ﹤0.01%
+2,073
New +$48.9K
TIS
1114
DELISTED
Orchids Paper Products, Inc.
TIS
$44K ﹤0.01%
5,390
-8,398
-61% -$101K
GOGO icon
1115
CALL
Gogo Inc
GOGO
$492M
$43K ﹤0.01%
+5,000
New +$48.2K
TPIC
1116
DELISTED
TPI Composites
TPIC
$43K ﹤0.01%
1,896
+900
+90% +$18.5K
QUOT
1117
DELISTED
Quotient Technology Inc
QUOT
$43K ﹤0.01%
3,300
+1,000
+43% +$12.7K
ACOR
1118
DELISTED
Acorda Therapeutics
ACOR
$43K ﹤0.01%
15
-13
-46% -$38.9K
RNR icon
1119
CALL
RenaissanceRe
RNR
$13.4B
$42K ﹤0.01%
300
ESIO
1120
DELISTED
Electro Scientific Industries
ESIO
$42K ﹤0.01%
2,168
-4,684
-68% -$94.3K
CNDT icon
1121
CALL
Conduent
CNDT
$264M
$41K ﹤0.01%
2,200
-100
-4% -$1.76K
CNDT icon
1122
Conduent
CNDT
$264M
$41K ﹤0.01%
2,180
-20
-0.9% -$352
BBBY
1123
DELISTED
Bed Bath & Beyond Inc
BBBY
$41K ﹤0.01%
1,950
+950
+95% +$21K
CLUB
1124
DELISTED
Town Sports International Holdings, Inc.
CLUB
$41K ﹤0.01%
+5,447
New +$34.7K
CI icon
1125
Cigna
CI
$74.6B
$40K ﹤0.01%
236
-390
-62% -$75.8K

Similar funds

Prelude Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Prelude Capital Management held 1,934 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prelude Capital Management deployed $91.6M of net new capital in Q1 2018, opening 622 new positions and adding to 464 existing holdings. Its largest new stake was XL Group Ltd.: 571,194 shares worth $31.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class B, an estimated $10.5M trimmed.

  • Prelude Capital Management's largest Q1 2018 buy was XL Group Ltd.: 571,194 shares worth $31.6M.
  • Prelude Capital Management added most to NXP Semiconductors in Q1 2018, an estimated $19.7M increase.
  • Prelude Capital Management's biggest Q1 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $10.5M.
  • Prelude Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $21.7M.
  • Prelude Capital Management's ten largest holdings make up 29% of its $1.38B portfolio in Q1 2018.
  • Prelude Capital Management opened 622 new positions and closed 465 in Q1 2018.
  • Prelude Capital Management's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.